SEC Tracker
Get the app
XAGE · XBRL financial data

Longevity Health Holdings financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (XAGE's year ends in late December)

In thousands of dollarsDec 31, 2021Dec 31, 2022†Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Revenue from contracts with customers——0501,913
Cost of goods and services sold——06818
Gross profit——0441,095
Research and development—2,1962,4971,054789
Total operating expenses—5,5085,9445,0428,202
Operating income (loss)—(1,651)(5,944)(4,998)(7,108)
Interest expense——342918
Income tax expense (benefit)—3910(97)36
Net income (loss)—205(15,445)(10,368)(6,905)
Earnings per share, basic USD per share—(5.47)(1.46)(0.49)(4.83)
Earnings per share, diluted USD per share—(5.47)(1.46)(0.49)(4.83)
Weighted average shares, basic thousands of shares—1,75711,02121,3631,430
Weighted average shares, diluted thousands of shares—1,75711,02121,3631,430
  • † Share count changed about 21x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/12 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (XAGE's year ends in late December)

In thousands of dollarsDec 31, 2021Dec 31, 2022†Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Cash and cash equivalents7741282,912157707
Accounts receivable——0437
Inventory—00109963
Total current assets97328562,9009561,950
Property and equipment, net—255193114102
Right-of-use asset—859832385300
Goodwill—0———
Total assets155,422156,97963,9491,4742,367
Accounts payable—2,1394,4174,0584,495
Accrued liabilities2151,258———
Total current liabilities3301,68238,5025,8777,916
Lease liability, non-current—828698310215
Total liabilities5,7357,08739,2006,1878,234
Accumulated deficit(4,763)(6,018)(58,503)(68,872)(75,777)
Total stockholders' equity(4,762)(6,018)24,749(4,713)(5,867)
Total liabilities and equity155,422156,97963,9491,4742,367
Common shares outstanding (cover page) thousands of shares—89719,24530,1202,475
  • † Share count changed about 21x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/12 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (XAGE's year ends in late December)

In thousands of dollarsDec 31, 2021Dec 31, 2022†Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Net income (loss)—205(15,445)(10,368)(6,905)
Stock-based compensation—636668827693
Depreciation and amortization—94978379
Net cash from operating activities—(489)(8,348)(4,389)(3,329)
Purchases of property and equipment—730—14
Net cash from investing activities—(7)(30)(749)(164)
Proceeds from issuing common stock———2,6873,484
Share repurchases—20——
Net cash from financing activities—(98)11,1632,3824,043
  • † Share count changed about 21x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/12 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 2840 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2840 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Longevity Health Holdings35396(224)*2.5M0.2 quarters 10-QJun 30, 2026
Caring Brands1,820not reported(463)*10.4M3.9 quarters 10-QJun 30, 2026
DSwiss25851250*206.9M— 10-QJun 30, 2026
Scientist Home Future Health14212(45)*23.7M— 10-QSep 30, 2026
cbdMD2,1185,554(442)*11.2M4.8 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.